换一批
换一批Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
作者：
主题词
成年人(Adult);老年人(Aged);贫血(Anemia);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);脱氧胞苷(Deoxycytidine);女(雌)性(Female);希腊(Greece);人类(Humans);中年人(Middle Aged);中性粒细胞减少(Neutropenia);紫杉酚(Paclitaxel);治疗结果(Treatment Outcome)
DOI
10.1081/cnv-200032980
PMID
15581045
发布时间
2022-12-07
- 浏览17
Cancer investigation
655-62页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
